| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.04 |